S Gastrointestinal And Liver Disease 12th Edition
To address entirely new clinical challenges, the 12th edition introduces several important new chapters and sections:
remains the gold-standard medical reference for gastroenterology and hepatology professionals worldwide. Released by Elsevier in December 2025, this fully updated two-volume masterwork continues a 50-year legacy of bridging basic science with cutting-edge clinical management. Led by a new generation of senior editors— Dr. Raymond T. Chung , Dr. David T. Rubin , and Dr. Mel Wilcox —the 12th edition delivers a modernized, global perspective on treating complex digestive and hepatic disorders. Core Specifications Overview
Sleisenger and Fordtran's Gastrointestinal and Liver Disease - 2 Volume Set - 12th Edition | Elsevier Shop
Comprehensive breakdowns of esophageal, gastric, pancreatic, biliary, intestinal, and hepatic diseases. s gastrointestinal and liver disease 12th edition
Designed for both deep study and quick clinical reference, the 12th edition includes:
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
The 12th edition is more than just a textbook; it is a comprehensive clinical partner. By integrating the latest genomic data, therapeutic breakthroughs, and diagnostic technologies, it ensures that practitioners are equipped to provide the best possible care for patients with digestive and liver disorders. To address entirely new clinical challenges, the 12th
: Quick-reference algorithms are used throughout to summarize complex decision-making and patient management.
3. Columnar and Squamous Diseases of the Esophagus and Stomach
: Hundreds of full-color endoscopic images, histological slides, and advanced radiological scans illustrate classic and rare disease presentations. Target Audience and Clinical Value Raymond T
Functional GI disorders (IBS, functional dyspepsia) are no longer considered "diagnoses of exclusion." The new edition integrates the latest Rome IV criteria and dedicates entire chapters to the neuroscience of the gut-brain axis. You will find updated algorithms for managing refractory IBS, including the role of dietary interventions (low FODMAP), gut-directed hypnotherapy, and novel pharmacological agents like tenapanor and ibodutant.
The field of clinical gastroenterology and hepatology evolves at a rapid pace. For decades, Sleisenger and Fordtran's Gastrointestinal and Liver Disease has served as the definitive cornerstone text for clinicians, researchers, and trainees worldwide. The release of the 12th edition marks a significant milestone in medical literature, delivering an unparalleled, comprehensive update to the pathophysiology, diagnosis, and management of digestive tract and hepatobiliary disorders.